IL45644A - 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives - Google Patents

3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives

Info

Publication number
IL45644A
IL45644A IL45644A IL4564474A IL45644A IL 45644 A IL45644 A IL 45644A IL 45644 A IL45644 A IL 45644A IL 4564474 A IL4564474 A IL 4564474A IL 45644 A IL45644 A IL 45644A
Authority
IL
Israel
Prior art keywords
hydrodibenzo
dihydroxyhexa
alkyl
pyran derivatives
pyran
Prior art date
Application number
IL45644A
Other languages
English (en)
Other versions
IL45644A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL45644A0 publication Critical patent/IL45644A0/xx
Publication of IL45644A publication Critical patent/IL45644A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL45644A 1973-11-05 1974-09-11 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives IL45644A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/413,010 US3968125A (en) 1973-11-05 1973-11-05 Dihydroxyhexahydrodibenzo[b,d]pyrans

Publications (2)

Publication Number Publication Date
IL45644A0 IL45644A0 (en) 1974-11-29
IL45644A true IL45644A (en) 1978-03-10

Family

ID=23635420

Family Applications (1)

Application Number Title Priority Date Filing Date
IL45644A IL45644A (en) 1973-11-05 1974-09-11 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives

Country Status (26)

Country Link
US (1) US3968125A (fr)
JP (1) JPS6033835B2 (fr)
AR (1) AR202318A1 (fr)
AT (1) AT336012B (fr)
BE (1) BE821716A (fr)
BG (1) BG26387A3 (fr)
CA (1) CA1023753A (fr)
CH (1) CH605894A5 (fr)
CS (1) CS193507B2 (fr)
DD (1) DD116230A5 (fr)
DE (1) DE2451934C2 (fr)
DK (1) DK136719B (fr)
ES (1) ES431674A1 (fr)
FR (1) FR2249664B1 (fr)
GB (1) GB1487637A (fr)
HU (1) HU169193B (fr)
IE (1) IE40023B1 (fr)
IL (1) IL45644A (fr)
NL (1) NL7414439A (fr)
PH (1) PH11788A (fr)
PL (2) PL95748B1 (fr)
RO (1) RO71766A (fr)
SE (1) SE415762B (fr)
SU (1) SU524517A3 (fr)
YU (1) YU36515B (fr)
ZA (1) ZA745751B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1522057A (en) * 1975-11-03 1978-08-23 Pfizer 9-hydroxydibenzo(b,d)pyrans and intermediates therefor
US4051152A (en) * 1976-01-07 1977-09-27 Sharps Associates Oxo C-ring benzopyrans
US4087546A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiasthmatic drugs
US4087545A (en) * 1976-02-17 1978-05-02 Eli Lilly And Company Hexahydro-dibenzo[b,d]pyran-9-ones as antiemetic drugs
SE7704749L (sv) * 1976-05-17 1977-12-05 Pfizer Kinoliner och forfarande och mellanprodukter for framstellning derav
US4054581A (en) * 1976-07-06 1977-10-18 Eli Lilly And Company Preparation of cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones and intermediates therefor
US4209520A (en) * 1977-06-17 1980-06-24 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4133819A (en) * 1977-06-17 1979-01-09 Pfizer Inc. Hexahydro-1-hydroxy-9-hydroxymethyl-3-substituted-6H-dibenzo[b,d]pyrans as analgesic agents
US4243674A (en) * 1978-06-12 1981-01-06 Pfizer Inc. 9-Hydroxydibenzo[b,d]pyrans and intermediates therefore
US4454144A (en) * 1982-06-21 1984-06-12 Pfizer Inc. Substituted dibenzo[b,d]pyran analgesics
JPS6299930U (fr) * 1985-12-12 1987-06-25
US8449908B2 (en) * 2000-12-22 2013-05-28 Alltranz, Llc Transdermal delivery of cannabidiol
EP1554572B1 (fr) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions et procedes de modulation du transport a travers la barriere hematho-encephalique
US20050101590A1 (en) * 2002-02-19 2005-05-12 Kiyoshi Yasui Antipruritics
CA2789262C (fr) 2005-04-28 2016-10-04 Proteus Digital Health, Inc. Systeme pharma-informatique
WO2008036682A2 (fr) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
MX2010001242A (es) * 2007-07-30 2010-07-02 Alltranz Inc Profarmacos de canabidiol, composiciones que comprenden profarmacos de canabidiol y metodos para utilizar los mismos.
WO2009099670A2 (fr) * 2008-02-08 2009-08-13 Nektar Therapeutics Al, Corporation Conjugués d'oligomère et de cannabinoïde
US20090247619A1 (en) * 2008-03-06 2009-10-01 University Of Kentucky Cannabinoid-Containing Compositions and Methods for Their Use
EP2398500B1 (fr) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Sustème d'administration de médicament à base de glutathionne
US8445002B2 (en) 2009-05-06 2013-05-21 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
US20200197357A1 (en) 2017-07-20 2020-06-25 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Compositions and methods of lipophilic drugs
EP3681474A1 (fr) 2017-09-11 2020-07-22 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions et procédés pour l'administration nasale de médicaments en direction du cerveau et en vue d'un effet systémique
US20200345656A1 (en) 2017-11-29 2020-11-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Cannabinoids compositions and methods
EP3873436A1 (fr) 2018-11-04 2021-09-08 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Compositions contenant des cannabinoïdes administrables par voie orale et procédés

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3507885A (en) * 1966-03-25 1970-04-21 Hoffmann La Roche 3-alkyl-6h-dibenzo(b,d)pyrans
US3636058A (en) * 1966-03-25 1972-01-18 Hoffmann La Roche 7 10 - dihydro - 3 - alkyl - 6h - dibenzo(b d) pyran-6 9(8h)-diones and 5-hydroxy-7-alkyl-4-chromanones
CH558792A (de) * 1971-10-14 1975-02-14 Petrzilka Theodor Verfahren zur herstellung von tetrahydrodibenzopyranen.

Also Published As

Publication number Publication date
FR2249664A1 (fr) 1975-05-30
PH11788A (en) 1978-07-05
JPS5071678A (fr) 1975-06-13
BE821716A (fr) 1975-04-30
DE2451934A1 (de) 1975-05-07
ES431674A1 (es) 1976-11-16
GB1487637A (en) 1977-10-05
DK136719C (fr) 1978-04-24
ATA886374A (de) 1976-08-15
DK573274A (fr) 1975-07-07
CH605894A5 (fr) 1978-10-13
PL93908B1 (fr) 1977-07-30
AU7321274A (en) 1976-03-18
DD116230A5 (fr) 1975-11-12
SE415762B (sv) 1980-10-27
FR2249664B1 (fr) 1978-03-24
DE2451934C2 (de) 1983-10-06
ZA745751B (en) 1976-04-28
RO71766A (fr) 1982-12-06
BG26387A3 (bg) 1979-03-15
IL45644A0 (en) 1974-11-29
SU524517A3 (ru) 1976-08-05
AT336012B (de) 1977-04-12
CA1023753A (fr) 1978-01-03
NL7414439A (nl) 1975-05-07
HU169193B (fr) 1976-10-28
IE40023L (en) 1975-05-05
DK136719B (da) 1977-11-14
JPS6033835B2 (ja) 1985-08-05
SE7413833L (fr) 1975-05-06
PL95748B1 (pl) 1977-11-30
IE40023B1 (en) 1979-02-28
YU36515B (en) 1984-02-29
YU265874A (en) 1982-02-25
US3968125A (en) 1976-07-06
AR202318A1 (es) 1975-05-30
CS193507B2 (en) 1979-10-31

Similar Documents

Publication Publication Date Title
IL45644A (en) 3-alkyl-1,9-dihydroxyhexa-hydrodibenzo(b,d)pyran derivatives
PH11009A (en) Triazolyl-o,n-acetals
IL45130A0 (en) Aminodibenzo (b,d) pyrans
ZA744331B (en) 1-hydroxyphenyl-2-amidoalkylaminoesthanol derivatives
CA1023385A (fr) 5-acetamido-2,4-dimethyltrifluoromethanesulfonanilide
MW1474A1 (en) Coumarin derivatives
IL44859A0 (en) Hydroxycoumarin derivatives
IL45807A0 (en) Derivatives of 7alpha-methylester-4-ene-3alpha,17beta-diols
ZA744364B (en) 4,3-dihydro-2h-naphthalin-1-one-5-oxypropyl-piperazine derivatives
PH10117A (en) Dibenzo(b,e)thiepine derivatives
ZA74932B (en) 7-alkyl-delta3,5-steroids
ZA743304B (en) 17beta-hydroxy-16,16-dimethylestr-4-en-3-one
AU7612874A (en) Benzopyran derivatives
CA1009234A (en) 2-methyl-5-substituted chromones
CA1010882A (en) 5-bromo-5-nitro-2-alkylsubstituted-1,3-dioxane
AU7365674A (en) Coumarin derivatives
GB1407940A (en) 6-aza-1h-1,4-bnezodiazepines
IE39704L (en) Dibenzothiepin and -oxepin derivatives.
IE42215L (en) Azetidinone derivatives.
AU483739B2 (en) Substituted trizzolo-1, 5-benzodiazephines
AU485289B2 (en) AMINODIBENZO I B, d PYRANS
AU478213B2 (en) 17b- hydroxy-16, 16-dimethylester-4-en-3-one
AU479172B2 (en) l, 3-DIOXANS
AU478031B2 (en) 5-bromo-5-nitro-2-alkylsubstituted-1, 3-dioxane
AU482712B2 (en) Substituted benzofurans